|
x € million
|
2010
|
2009
|
2008
|
2007
|
2006
|
|
Assets
|
|||||
|
Intangible assets
|
1,070
|
1,053
|
1,200
|
1,037
|
1,008
|
|
Property, plant and equipment
|
2,943
|
3,477
|
3,641
|
3,440
|
3,655
|
|
Deferred tax assets
|
326
|
322
|
392
|
346
|
496
|
|
Prepaid pension costs
|
1
|
282
|
137
|
1,169
|
918
|
|
Associates
|
25
|
18
|
19
|
20
|
26
|
|
Other financial assets
|
270
|
233
|
176
|
126
|
100
|
|
Non-current assets
|
4,635
|
5,385
|
5,565
|
6,138
|
6,203
|
|
Inventories
|
1,340
|
1,359
|
1,765
|
1,547
|
1,515
|
|
Receivables
|
1,477
|
1,410
|
1,632
|
1,687
|
1,739
|
|
Financial derivatives
|
134
|
88
|
86
|
83
|
79
|
|
Current investments
|
837
|
7
|
4
|
4
|
3
|
|
Cash and cash equivalents
|
1,453
|
1,340
|
601
|
369
|
552
|
|
5,241
|
4,204
|
4,088
|
3,690
|
3,888
|
|
|
Assets to be contributed to joint ventures
|
317
|
-
|
-
|
-
|
-
|
|
Other assets held for sale
|
287
|
25
|
-
|
-
|
-
|
|
Current assets
|
5,845
|
4,229
|
4,088
|
3,690
|
3,888
|
|
Total assets
|
10,480
|
9,614
|
9,653
|
9,828
|
10,091
|
|
Equity and liabilities
|
|||||
|
Royal DSM N.V. Shareholders' equity
|
5,481
|
4,949
|
4,633
|
5,310
|
5,784
|
|
Non-controlling interests
|
96
|
62
|
62
|
73
|
71
|
|
Equity
|
5,577
|
5,011
|
4,695
|
5,383
|
5,855
|
|
Deferred tax liabilities
|
155
|
115
|
122
|
344
|
383
|
|
Employee benefits liabilities
|
297
|
298
|
314
|
273
|
304
|
|
Provisions
|
93
|
103
|
190
|
170
|
188
|
|
Borrowings
|
1,992
|
2,066
|
1,559
|
1,560
|
907
|
|
Other non-current liabilities
|
33
|
49
|
65
|
35
|
44
|
|
Non-current liabilities
|
2,570
|
2,631
|
2,250
|
2,382
|
1,826
|
|
Employee benefits liabilities
|
24
|
26
|
33
|
9
|
21
|
|
Provisions
|
33
|
102
|
82
|
91
|
127
|
|
Borrowings
|
105
|
138
|
734
|
192
|
607
|
|
Financial derivatives
|
219
|
61
|
179
|
42
|
41
|
|
Current liabilities
|
1,789
|
1,638
|
1,680
|
1,729
|
1,614
|
|
2,170
|
1,965
|
2,708
|
2,063
|
2,410
|
|
|
Liabilities to be contributed to joint ventures
|
104
|
-
|
-
|
-
|
-
|
|
Other liabilities held for sale
|
59
|
7
|
-
|
-
|
-
|
|
Current liabilities
|
2,333
|
1,972
|
2,708
|
2,063
|
2,410
|
|
Total equity and liabilities
|
10,480
|
9,614
|
9,653
|
9,828
|
10,091
|
|
x € million
|
2010
|
2009
|
2008
|
2007
|
2006
|
|
Net sales
|
9,050
|
7,866
|
9,297
|
8,757
|
8,380
|
|
Operating profit plus depreciation and amortization (EBITDA)
|
1,278
|
917
|
1,357
|
1,247
|
1,274
|
|
Operating profit (EBIT)
|
838
|
443
|
903
|
823
|
834
|
|
Net finance costs
|
(93)
|
(113)
|
(102)
|
(75)
|
(81)
|
|
Income tax expense
|
(185)
|
(83)
|
(196)
|
(183)
|
(198)
|
|
Share of the profit of associates
|
5
|
(4)
|
(3)
|
(2)
|
1
|
|
Net profit before exceptional items
|
565
|
243
|
602
|
563
|
556
|
|
Net profit from exceptional items
|
(40)
|
93
|
(31)
|
(129)
|
(4)
|
|
Profit for the year
|
525
|
336
|
571
|
434
|
552
|
|
Profit attributable to non-controlling interests
|
(18)
|
1
|
6
|
(5)
|
(5)
|
|
Net profit attributable to equity holders of Royal DSM N.V.
|
507
|
337
|
577
|
429
|
547
|
|
Dividend on cumulative preference shares
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
|
Net profit available to holders of ordinary shares
|
497
|
327
|
567
|
419
|
537
|
|
Key figures and ratios
|
|||||
|
Capital employed1
|
5,468
|
5,673
|
6,558
|
5,982
|
6,303
|
|
Capital expenditure:
|
|||||
|
- Intangible assets and Property, plant and equipment
|
427
|
472
|
587
|
475
|
457
|
|
- Acquisitions
|
49
|
(5)
|
152
|
93
|
44
|
|
Disposals
|
377
|
287
|
27
|
52
|
165
|
|
Depreciation and amortization
|
440
|
474
|
454
|
424
|
451
|
|
Net debt
|
(108)
|
830
|
1,781
|
1,338
|
921
|
|
Dividend
|
234
|
205
|
204
|
214
|
197
|
|
Workforce at 31 December, headcount (x 1000)
|
22
|
23
|
24
|
23
|
22
|
|
Employee benefits costs (x € million)
|
1,566
|
1,532
|
1,465
|
1,389
|
1,332
|
|
Ratios1
|
|||||
|
- ROCE in %
|
15.0
|
7.2
|
14.4
|
13.4
|
13.4
|
|
- Net sales / average capital employed
|
1.62
|
1.29
|
1.48
|
1.43
|
1.34
|
|
- Current assets / current liabilities
|
2.42
|
2.14
|
1.51
|
1.78
|
1.61
|
|
- Equity / total assets
|
0.53
|
0.52
|
0.49
|
0.55
|
0.58
|
|
- Gearing (net debt / equity plus net debt)
|
(0.02)
|
0.14
|
0.28
|
0.20
|
0.14
|
|
- EBIT / net sales in %
|
9.3
|
5.6
|
9.7
|
9.4
|
10.0
|
|
- CFROI in %
|
9.2
|
6.1
|
8.7
|
8.3
|
8.5
|
|
- Net profit / average Royal DSM N.V. Shareholders' equity available to holders of ordinary shares in %
|
10.0
|
7.2
|
11.9
|
7.9
|
9.9
|
|
- EBITDA / net finance costs
|
13.7
|
8.1
|
13.3
|
16.6
|
15.7
|
|
per ordinary share in €
|
2010
|
2009
|
2008
|
2007
|
2006
|
|
Net profit before exceptional items
|
3.27
|
1.44
|
3.64
|
3.07
|
2.85
|
|
Net profit
|
3.03
|
2.01
|
3.45
|
2.35
|
2.83
|
|
Cash flow
|
5.62
|
6.05
|
6.20
|
5.56
|
5.21
|
|
Royal DSM N.V. Shareholders' equity
|
31.52
|
28.92
|
27.12
|
30.42
|
30.03
|
|
Dividend:
|
1.351
|
1.20
|
1.20
|
1.20
|
1.00
|
|
- Interim dividend
|
0.40
|
0.40
|
0.40
|
0.33
|
0.33
|
|
- Final dividend
|
0.95
|
0.80
|
0.80
|
0.87
|
0.67
|
|
Pay-out including dividend on cumulative preference shares as % of net profit before exceptional items
|
38
|
84
|
36
|
35
|
38
|
|
Dividend yield (dividend as % of average price of an ordinary DSM share)
|
3.8
|
4.8
|
3.9
|
3.3
|
2.9
|
|
Share prices on NYSE Euronext Amsterdam (closing price):
|
|||||
|
- Highest price
|
42.85
|
34.84
|
41.27
|
39.87
|
39.70
|
|
- Lowest price
|
30.43
|
16.93
|
15.76
|
31.63
|
28.58
|
|
- At 31 December
|
42.61
|
34.46
|
18.33
|
32.33
|
37.43
|
|
(x 1000)
|
|||||
|
Number of ordinary shares outstanding:
|
|||||
|
- At 31 December
|
166,468
|
163,037
|
162,227
|
166,897
|
184,850
|
|
- Average
|
164,047
|
162,364
|
164,196
|
178,541
|
189,550
|
|
Daily trading volumes on NYSE Euronext Amsterdam:
|
|||||
|
- Average
|
995
|
1,270
|
1,783
|
1,590
|
1,301
|
|
- Lowest
|
85
|
75
|
152
|
94
|
267
|
|
- Highest
|
3,629
|
4,376
|
5,894
|
11,347
|
5,268
|